Estrogen Attenuates Local Inflammasome Expression and Activation after Spinal Cord Injury

Mol Neurobiol. 2018 Feb;55(2):1364-1375. doi: 10.1007/s12035-017-0400-2. Epub 2017 Jan 27.

Abstract

17-estradiol (E2) is a neuroprotective hormone with a high anti-inflammatory potential in different neurological disorders. The inflammatory response initiated by spinal cord injury (SCI) involves the processing of interleukin-1beta (IL-1b) and IL-18 mediated by caspase-1 which is under the control of an intracellular multiprotein complex called inflammasome. We recently described in a SCI model that between 24 and 72 h post-injury, most of inflammasome components including IL-18, IL-1b, NLRP3, ASC, and caspase-1 are upregulated. In this study, we investigated the influence of E2 treatment after spinal cord contusion on inflammasome regulation. After contusion of T9 spinal segment, 12-week-old male Wistar rats were treated subcutaneously with E2 immediately after injury and every 12 h for the next 3 days. Behavioral scores were significantly improved in E2-treated animals compared to vehicle-treated groups. Functional improvement in E2-treated animals was paralleled by the attenuated expression of certain inflammasome components such as ASC, NLRP1b, and NLRP3 together with IL1b, IL-18, and caspase-1. On the histopathological level, microgliosis and oligodendrocyte injury was ameliorated. These findings support and extend the knowledge of the E2-mediated neuroprotective function during SCI. The control of the inflammasome machinery by E2 might be a missing piece of the puzzle to understand the anti-inflammatory potency of E2.

Keywords: Estrogen; Inflammasome; Spinal cord injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Estradiol / pharmacology*
  • Estradiol / therapeutic use
  • Inflammasomes / drug effects*
  • Inflammasomes / metabolism
  • Interleukin-18 / metabolism
  • Interleukin-1beta / metabolism
  • Male
  • Motor Skills / drug effects
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Rats
  • Rats, Wistar
  • Recovery of Function / drug effects*
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / metabolism*

Substances

  • Inflammasomes
  • Interleukin-18
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Neuroprotective Agents
  • Nlrp3 protein, rat
  • Estradiol